APA (7th ed.) Citation

Antonik, L. J., Goldwater, D. R., Kilpatrick, G. J., Tilbrook, G. S., & Borkett, K. M. (2012). A Placebo- and Midazolam-Controlled Phase I Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam (CNS 7056): Part I. Safety, Efficacy, and Basic Pharmacokinetics. Anesthesia and analgesia, 115(2), 274-283. https://doi.org/10.1213/ANE.0b013e31823f0c28

Chicago Style (17th ed.) Citation

Antonik, Laurie J., D. Ronald Goldwater, Gavin J. Kilpatrick, Gary S. Tilbrook, and Keith M. Borkett. "A Placebo- and Midazolam-Controlled Phase I Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam (CNS 7056): Part I. Safety, Efficacy, and Basic Pharmacokinetics." Anesthesia and Analgesia 115, no. 2 (2012): 274-283. https://doi.org/10.1213/ANE.0b013e31823f0c28.

MLA (9th ed.) Citation

Antonik, Laurie J., et al. "A Placebo- and Midazolam-Controlled Phase I Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam (CNS 7056): Part I. Safety, Efficacy, and Basic Pharmacokinetics." Anesthesia and Analgesia, vol. 115, no. 2, 2012, pp. 274-283, https://doi.org/10.1213/ANE.0b013e31823f0c28.